top of page
SANNARCH PHARMA AND HEALTHCARES logo

     SANNARCH PHARMA AND HEALTHCARES

SANNARCH PHARMA

Securing First-Time Right compliance through corporate Quality Assurance leadership and AI-driven quality validation. Precision and excellence in every regulatory framework.

AI-DRIVEN VALIDATION • QA LEADERSHIP • FIRST-TIME RIGHT

Available for Global Remote Advisory & On-Site Audits

Our Team of Strategic QA Consultant and Certified ISO : Lead Auditor is dedicated to driving zero-defect manufacturing, USFDA/MHRA audit success, and Pharma 4.0 digital transformation

Founder and Strategic Pharma Consultant

PRINCIPAL PHARMA QUALITY ASSURANCE CONSULTANT. certified iso 9001:2015 lead auditor. AI Intelligence. First-Time Right Compliance.

Led by an elite team of Ex-Corporate QA Leadership and over two decades of combined team experience and track records of clearing multiple USFDA Inspection (USFDA, MHRA, TGA, WHO-GMP). Uniquely positioned at the intersection of traditional GxP rigor and modern Pharma 4.0 digital transformation. At Sannarch Pharma, our objective is to empower pharmaceutical organizations to achieve "First-Time Right" compliance in high-risk Oncology and Sterile manufacturing. By integrating deep Subject Matter Expertise (SME) with AI-driven QMS strategies, we deliver risk-mitigating solutions that ensure zero-defect manufacturing, flawless audit success, and robust corporate governance

CORE COMPETENCIES
  • Regulatory & Compliance: USFDA / MHRA / TGA Audit Readiness, ISO 9001:2015 Lead Auditing, Form 483 & Warning Letter Remediation, Global Vendor Governance.
  • Technical SME: Oncology Pilot Plants Set-up, Aseptic Fill-Finish, Lyophilisation, Sterile Line Validation.
  • Digital & Pharma 4.0: AI-Integrated QMS, 21 CFR Part 11 Compliance, Data Integrity, Automated Workflow Validation (Track Wise, SAP and LIMS).
  • Project Management: Strategic CAPA implementation, cross-functional team leadership, and compliance project execution.
  • Global Data Privacy Compliance : Certified expertise in EU-GDPR and India DPDPA 2023 to ensure your digital QMS, clinical data, and Pharma 4.0 Integrations meet strict international privacy laws.​

Consulting Service Tiers

Authoritative frameworks designed to secure First-Time Right compliance and strategic operational foresight.

Strategic Advisory Call

1-hour deep-dive for immediate regulatory clarity and 'First-Time Right' guidance.

Fee: $250 / Hour
Technical Document Review

Comprehensive GAP analysis of CMC, BMR, or Quality manuals to ensure inspection readiness.

Fee: From $750
Mock USFDA Audit

Authoritative site simulation clearing potential FDA/WHO findings before they occur.

Fee: From $2700
Project Retainer

Authoritative Corporate QA leadership and monthly audit readiness support for global multi-site operations.

Custom Quote

Career Authority

17+

Years Leadership. Authoritative Corporate QA leadership and global regulatory excellence driving multi-site healthcare operations.

5+

FDA/WHO Clearances. Successfully cleared 5+ major USFDA and WHO inspections with zero critical findings, securing 'First-Time Right' compliance.

AI

Intelligence & Validation. Pioneering AI-driven compliance and CSA (Computer Software Assurance) frameworks for predictive quality management.

100%

Audit Readiness. Consistent 100% success rate in regulatory plant readiness and First-Time Right compliance certifications globally.

Professional Experience

2007 – 2014

Founder & Principal Consultant | SANNARCH Pharma Compliance

Leading a new era of 'First-Time Right' compliance by merging traditional GxP rigor with AI-driven intelligence. Consulting offerings include: Strategic Advisory Call (Investment from $250), Technical Document Review ($7,50), Mock USFDA Audit ($2,700+), and executive Project Retainer agreements for multi-site global healthcare infrastructures.

Corporate QA Leadership | Enterprise Pharmaceutical Services

Orchestrated authoritative corporate QA benchmarks and cleared 5+ major USFDA, MHRA, and EMA inspections with zero critical notifications. Leveraged 17+ years of expertise to drive 'First-Time Right' compliance success across multi-site global healthcare infrastructures.

Regional Head of Quality Systems | Global Healthcare Solutions

Directed cross-functional GxP validation projects and modernized legacy quality systems for high-performance compliance across 20+ countries. Specialized in integrating predictive risk mitigation frameworks for consistent regulatory excellence.

Senior Compliance Specialist | International Regulatory Advisors

Executed rigorous GAP analysis and risk-based validation for global pharmaceutical supply chains. Early implementation of predictive compliance patterns and authoritative adherence to MHRA and FDA standards.

2026 – PRESENT

2016 – 2025

2014 – 2016

Consulting Service Offerings

CORE COMPETENCIES & EXPERTISE

USFDA & GLOBAL INSPECTION READINESS
AI-DRIVEN VALIDATION & CSV/CSA
AUTHORITATIVE QA LEADERSHIP

Success clearing 5+ USFDA and MHRA inspections. Leveraging 17+ years of traditional rigor to ensure 'First-Time Right' regulatory excellence for global healthcare enterprises.

Integrating AI intelligence with Computer Software Assurance (CSA) protocols. Transforming traditional quality rigor into predictive compliance assets for modern operations.

Authoritative oversight and multi-site remediation. Executive leadership focused on operational foresight, systemic precision, and securing institutional trust.

Traditional Rigor.
AI Intelligence.
Global Regulatory Excellence.

01

Global Regulatory Excellence

Leveraging 17+ years of expertise to clear 5+ major USFDA and WHO inspections with zero critical findings. We secure authoritative compliance for global healthcare multi-site operations.

02

AI-Grounded Precision

Merging traditional GxP rigor with AI-driven validation and CSA protocols. Our predictive intelligence identifies quality gaps before they occur, ensuring 'First-Time Right' compliance as a strategic asset.

03

Authoritative GxP Tenure

Strategic leadership in Corporate QA focused on zero-error quality systems. Bridging complex regulatory requirements with intelligent automation to empower enterprise-wide operational excellence.

Ready to Secure First-Time Right Compliance?

Traditional Rigor. AI Intelligence. First-Time Right compliance. Leverage over 17 years of authoritative QA leadership and success clearing 5+ USFDA/WHO inspections to secure global regulatory excellence.

Strategic Service Tiers: Authoritative Regulatory Excellence

Strategic Advisory Call

Direct leadership consultation focusing on high-stakes USFDA decision-making and AI validation strategy. Indicative Fee: Starting at $250/session.

Technical Document Review

Deep-tier audit of validation protocols and CSA data frameworks to secure technical First-Time Right clearance. Indicative Fee: Custom Quote.

Mock USFDA Audit

Authoritative inspection simulation to identify regulatory gaps and implement predictive remediation models. Indicative Fee: Service Tiered.

Project Retainer

Continuous corporate QA advisory and multi-site global compliance leadership on a dedicated retainer basis. Indicative Fee: Monthly Retainer.

COMMERCIAL TERMS & POLICY

Section I: Financial Remuneration and Billing Protocols
1. Engagement Initiation: These terms define the fiscal obligations for all high-stakes corporate consulting mandates.
2. Mobilization Retainer: A non-refundable advance of 50% is mandatory for all projects with a valuation exceeding  $1000 prior to commencement.
3. Final Settlement: The outstanding balance shall be remunerated in full within 15 calendar days following the submission of the final deliverable.
4. Statutory Levies: All quoted professional fees are exclusive of GST, which shall be applied at the prevailing statutory rate.

Section II: Terms of Engagement and Operational Conduct
1. Operational Integrity: Regulations are established to safeguard proprietary pharmaceutical assets and maximize on-site performance.
2. Reimbursable Expenses: Business travel, premium lodging (minimum 4-star standard), and local transit for off-site assignments shall be invoiced at actual cost.
3. Non-Disclosure: All professional services are governed by a legally binding mutual Non-Disclosure Agreement (NDA) to ensure data confidentiality.
4. Billable Units: A standard consulting unit is defined as 8 billable hours per day.

Consulting Service Tiers: Strategic Advisory Call ($250/hr) • Technical Document Review (from $750) • Mock USFDA Audit (from $2700) • Project Retainer (Custom Quote)

Book a Strategic Advisory & Direct Contact

Authorize your regulatory success through specialized advisory levels tailored for global pharmaceutical excellence.

Traditional Rigor. AI Intelligence. First-Time Right compliance.

• Strategic Advisory Call: High-level guidance.
• Technical Document Review: Compliance deep-dive.
• Mock USFDA Audit: Site readiness.
• Project Retainer: Sustained oversight.
*Indicative fees from presentation available.

Direct Consultation Tiers

India Global Hub

Headquarters: Global Regulatory Center, India.
Email: info@sannarchpharmaandhealthcare.com

Direct Line: +91 9769994515

Engage Direct Leadership

  • Direct Line: +91 9769994515, WhatsApp Number : 9769994515
  • Official Email: info@sannarchpharmaandhealthcare.com
  • HQ Address: Navi Mumbai, India
  • Registered Office: Panchkula, Haryana (India)
Consulting Service Tiers

Tier I - Strategic Advisory Call : 1-Hour immediate consultation or 483 response direction ($250/hr)
Tier II - Technical Document Review: SME Audit of BMR, MFR, or critical Validation Protocols/SOPs ($ 750 / Documents)

Tier III - Mock USFDA Audit: 3-Day On-Site/Remote Compliance Assessment & Gap Report. ($ 2700 / Site)
Tier IV - Project Retainer: Continuous QA leadership for global operations or Warning Letter support (Custom Quote)

Book a Strategic Audit Call

Secure USFDA/MHRA readiness audits and digital validation automation with First-Time Right leadership. Reach out to coordinate your strategic compliance setup.

Executive Consulting Inquiry

Please provide your details below to initiate a professional consultation regarding our pharmaceutical advisory services.

Area of Interest

Select the primary focus of your inquiry.

bottom of page